Minal K. Patel, MD, from the World Health Organization, answered our questions about her team’s research on the continued progress toward regional and global measles elimination from 2000 to 2018.
Sachiko Ozawa, PhD, MHS—the lead author of a new review that aimed to define hard-to-reach and hard-to-vaccinate populations—answers our questions about her latest review and about vaccine hesitancy.
Consultant360 spoke with Michael J. Wilkinson, MD, whose study found that 10-hour time-restricted eating may aid in the reversal and prevention of metabolic syndrome.
The authors of a recent study examined the safety and clinical efficacy of using mepolizumab to treat patients with HES. First author Florence Roufosse, MD, PhD, answered Consultant360’s questions on the...
The lead authors of a new study about the 20-year financial and health burdens of asthma—J. Mark FitzGerald, MD, and Mohsen Sadatsafavi, MD, PhD—answer our questions about its findings.
Dafna D. Gladman, MD, from the University of Toronto, answers our questions about her research that determined the prevalence and incidence of liver abnormalities in patients with psoriatic arthritis.
In this Q&A, lead author Shahina Pardhan, PhD, discusses her study that found dual sensory impairment is associated with increased depression and anxiety, with women showing stronger associations than...
Claudia Crimi, MD, PhD, and colleagues recently compared Asthma Control Test scores obtained by patients vs physicians. The research highlights the need for physicians to carefully evaluate patients'...
What is the association between depression and subsequent risk of rheumatoid arthritis by serologic phenotype? In this Q&A, Jeffrey Sparks, MD, explains.
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
